Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
Moss JG, Wu O, Bodenham AR, Agarwal R, Menne TF, Jones BL, Heggie R, Hill S, Dixon-Hughes J, Soulis E, Germeni E, Dillon S, McCartney E; CAVA trial group.
Moss JG, et al.
Lancet. 2021 Jul 31;398(10298):403-415. doi: 10.1016/S0140-6736(21)00766-2. Epub 2021 Jul 21.
Lancet. 2021.
PMID: 34297997
Free article.
Clinical Trial.